影像、檢驗及病理科系

生化檢驗科的依據指引

14 個學習主題共依據 17 份臨床指引與文獻。點主題名稱看它的學習重點。

肝功能指標檢驗1 份

  1. Guidelines on the management of abnormal liver blood tests|BSG|2018
    BSG的全部指引 · Newsome PN, Cramb R, Davison SM, et al. · DOI · CC BY

腎功能指標與電解質檢驗1 份

  1. Renal function assessment: creatinine, cystatin C and the EKFC equation|Advances in Laboratory Medicine|2024
    Pottel H, Delanaye P, Cavalier E · DOI · CC BY-NC 4.0

血糖與糖化血色素檢驗1 份

  1. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus|ADA + ADLM 聯合|2023
    ADA的全部指引 · Sacks DB, Arnold M, Bakris GL, et al. · DOI

血脂質與心血管風險指標1 份

  1. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications — joint consensus statement|EAS + EFLM 聯合|2016
    Nordestgaard BG, Langsted A, Mora S, et al. · DOI · CC BY-NC 4.0

心肌酵素與心臟標記檢驗1 份

  1. NACB Laboratory Medicine Practice Guidelines: Use of Cardiac Biomarkers|NACB/Clinical Chemistry|2007

電解質與酸鹼平衡1 份

  1. Blood gas testing and related measurements: National recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine|克羅埃西亞醫學生化與檢驗醫學學會|2016
    Dukić L, Milevoj Kopčinović L, Dorotić A, et al. · DOI · CC BY

甲狀腺與內分泌荷爾蒙檢驗1 份

  1. Thyroid Stimulating Hormone and Thyroid Hormones (T3 and T4): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status|ATA|2023
    Van Uytfanghe K, Ehrenkranz J, Halsall D, et al. · DOI · CC BY 4.0

腫瘤標記檢驗2 份

  1. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers|Clinical Chemistry|2010
    Sturgeon CM, Duffy MJ, Hofmann BR, et al. · DOI
  2. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers|Clinical Chemistry|2008
    Sturgeon CM, Duffy MJ, Stenman UH, et al. · DOI

蛋白質與白蛋白電泳2 份

  1. Paradigm Shift in Monoclonal Protein Detection: From Electrophoresis-based to Mass Spectrometry–based Methods|Annals of Laboratory Medicine|2025
    Lee J, Yoo S, Yang S, et al. · DOI · CC BY-NC 4.0
  2. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders|Leukemia|2008
    Dispenzieri A, Kyle R, Merlini G, et al. · DOI

尿液生化與微量白蛋白1 份

  1. Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for CKD|EFLM Task Group on CKD|2024
    Cavalier E, Zima T, Datta P, et al. · DOI

治療藥物濃度監測1 份

  1. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper|多學會聯合|2020
    Abdul-Aziz MH, Alffenaar JWC, Bassetti M, et al. · DOI

生化分析儀原理與干擾因素2 份

  1. Interferences from blood collection tube components on clinical chemistry assays|Biochemia Medica|2014
    Bowen RAR, Remaley AT · DOI · CC BY
  2. Lipemia: causes, interference mechanisms, detection and management|Biochemia Medica|2014
    Nikolac N · DOI · CC BY

維生素與微量元素檢驗1 份

  1. Vitamin D Controversies in the Laboratory Medicine: A Review of Clinical Guidelines and Recommendations|eJIFCC|2024

先天性代謝異常與新生兒篩檢生化1 份

  1. Liquid Chromatography–Tandem Mass Spectrometry in Newborn Screening Laboratories|International Journal of Neonatal Screening|2022
    Gelb MH, Basheeruddin K, Burlina A, et al. · DOI · CC BY 4.0

使用 Google 帳號登入,第一次登入時選擇科別即可開始;已經在用?直接登入